GlassScriptPhysician profile
Ashlee N Pinkston
NPI 1083131056
$886.23
in general payments reported to CMS, 2019-2025
20 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $351 · 2022: $78.49 · 2023: $76.34 · 2024: $172 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $124.74 | 2024 | |
| Janssen Scientific Affairs, LLC | $124.74 | 2021 | |
| Ethicon US, LLC | $107.70 | 2021-2025 | Echelon; Endopath, Echelon Endopath, Echelon Flex |
| Atricure, INC. | $61.66 | 2022-2024 | |
| Ethicon INC. | $56.53 | 2021 | |
| Davol INC. | $44.35 | 2021 | |
| Stryker Corporation | $42.50 | 2021-2025 | Na |
| Chiesi USA, INC. | $41.89 | 2021 | |
| Lemaitre Vascular, INC. | $36.43 | 2025 | Xenosure Biologic Patch |
| Bard Peripheral Vascular, INC. | $32.19 | 2021 | |
| Abbott Laboratories | $30.48 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| W. L. Gore & Associates, INC. | $29.43 | 2023-2025 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Baxter Healthcare | $26.92 | 2023 | Preveleak |
| Solventum Corporation | $22.20 | 2025 | Prevena |
| Bolton Medical INC | $19.90 | 2025 | Thoraflex Hybrid, Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.19 | 2023 | Ozempic, Rybelsus |
| Medtronic, INC. | $17.41 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.98 | 2021 | |
| Kci USA, INC. | $16.09 | 2023 | Prevena, V.A.C. Dermatac, V.A.C.Ulta |
| Biotronik INC. | $14.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlee Pinkston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.